Abstract
Transcriptomics in combination with in vitro cell systems is a powerful approach to unravel modes of action of toxicants. An important question is to which extent the modes of action as revealed by transcriptomics depend on cell type, species and study type (in vitro or in vivo). To acquire more insight into this, we assessed the transcriptomic effects of the immunosuppressive drug cyclosporine A (CsA) upon 6 h of exposure of the mouse cytotoxic T cell line CTLL-2, the thymoma EL-4 and primary splenocytes and compared these to the effects in spleens of mice orally treated with CsA for 7 days. EL-4 and CTLL-2 cells showed the highest similarities in response. CsA affected many genes in primary splenocytes that were not affected in EL-4 or CTLL-2. Pathway analysis demonstrated that CsA upregulated the unfolded protein response, endoplasmic reticulum stress and NRF2 activation in EL-4 cells, CTLL-2 cells and primary mouse splenocytes but not in mouse spleen in vivo. As expected, CsA downregulated cell cycle and immune response in splenocytes in vitro, spleens in vivo as well as CTLL-2 in vitro. Genes up- and downregulated in human Jurkat, HepG2 and renal proximal tubular cells were similarly affected in CTLL-2, EL-4 and primary splenocytes in vitro. In conclusion, of the models tested in this study, the known mechanism of immunotoxicity of CsA is best represented in the mouse cytotoxic T cell line CTLL-2. This is likely due to the fact that this cell line is cultured in the presence of a T cell activation stimulant (IL-2) making it more suitable to detect inhibitory effects on T cell activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baken KA, Pennings JL, Jonker MJ et al (2008) Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening. Toxicol Appl Pharmacol 226(1):46–59. doi:10.1016/j.taap.2007.08.026
Bar-Joseph Z, Siegfried Z, Brandeis M et al (2008) Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells. Proc Natl Acad Sci USA 105(3):955–960. doi:10.1073/pnas.0704723105
Bram RJ, Hung DT, Martin PK, Schreiber SL, Crabtree GR (1993) Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol 13(8):4760–4769
Civelek M, Manduchi E, Riley RJ, Stoeckert CJ Jr, Davies PF (2009) Chronic endoplasmic reticulum stress activates unfolded protein response in arterial endothelium in regions of susceptibility to atherosclerosis. Circ Res 105(5):453–461. doi:10.1161/CIRCRESAHA.109.203711
Clipstone NA, Crabtree GR (1992) Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357(6380):695–697. doi:10.1038/357695a0
Corsini E, Roggen EL (2009) Immunotoxicology: opportunities for non-animal test development. Altern Lab Anim 37(4):387–397
Cristillo AD, Bierer BE (2002) Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis. J Biol Chem 277(6):4465–4476. doi:10.1074/jbc.M108598200
de Arriba G, Calvino M, Benito S, Parra T (2013) Cyclosporine A-induced apoptosis in renal tubular cells is related to oxidative damage and mitochondrial fission. Toxicol Lett 218(1):30–38. doi:10.1016/j.toxlet.2013.01.007
Deters M, Klabunde T, Meyer H, Resch K, Kaever V (2003) Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat. Planta Med 69(4):337–343. doi:10.1055/s-2003-38870
Du J, Yu Y, Tu H et al (2006) New insights on macrophage migration inhibitory factor: based on molecular and functional analysis of its homologue of Chinese amphioxus. Mol Immunol 43(13):2083–2088. doi:10.1016/j.molimm.2005.12.007
Du S, Hiramatsu N, Hayakawa K et al (2009) Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol 182(11):7201–7211. doi:10.4049/jimmunol.0801772
Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95(25):14863–14868
Erdem SR, Emre-Aydingoz S, Atilla P et al (2011) Cyclosporine A-induced acute hepatotoxicity in guinea pigs is associated with endothelin-mediated decrease in local hepatic blood flow. Life Sci 88(17–18):753–760. doi:10.1016/j.lfs.2011.02.015
Galat A, Bua J (2010) Molecular aspects of cyclophilins mediating therapeutic actions of their ligands. Cell Mol Life Sci 67(20):3467–3488. doi:10.1007/s00018-010-0437-0
Gottschalk AR, Boise LH, Thompson CB, Quintans J (1994) Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91(15):7350–7354
Halestrap AP, Connern CP, Griffiths EJ, Kerr PM (1997) Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 174(1–2):167–172
Hama T, Nakanishi K, Mukaiyama H et al (2013) Endoplasmic reticulum stress with low-dose cyclosporine in frequently relapsing nephrotic syndrome. Pediatr Nephrol. doi:10.1007/s00467-012-2403-6
Hibino M, Sugiura K, Muro Y, Shimoyama Y, Tomita Y (2011) Cyclosporin A induces the unfolded protein response in keratinocytes. Arch Dermatol Res 303(7):481–489. doi:10.1007/s00403-010-1099-3
Ho S, Clipstone N, Timmermann L et al (1996) The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80(3 Pt 2):S40–S45
Hochreiter-Hufford A, Ravichandran KS (2013) Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol 5(1):a008748. doi:10.1101/cshperspect.a008748
Hochstenbach K, van Leeuwen DM, Gmuender H et al (2010) Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells. Toxicol Sci 118(1):19–30. doi:10.1093/toxsci/kfq239
Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH (2003) Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 4(4):321–329. doi:10.1038/ni907
Jeon SH, Piao YJ, Choi KJ et al (2005) Prednisolone suppresses cyclosporin A-induced apoptosis but not cell cycle arrest in MDCK cells. Arch Biochem Biophys 435(2):382–392. doi:10.1016/j.abb.2005.01.003
Johnson EN, Lee YM, Sander TL et al (2003) NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem 278(3):1686–1692. doi:10.1074/jbc.M210250200
Kahl CR, Means AR (2004) Calcineurin regulates cyclin D1 accumulation in growth-stimulated fibroblasts. Mol Biol Cell 15(4):1833–1842. doi:10.1091/mbc.E03-10-0730
Katika MR, Hendriksen PJ, van Loveren H, Peijnenburg A (2011) Exposure of Jurkat cells to bis (tri-n-butyltin) oxide (TBTO) induces transcriptomics changes indicative for ER- and oxidative stress, T cell activation and apoptosis. Toxicol Appl Pharmacol 254(3):311–322. doi:10.1016/j.taap.2011.04.021
Kienhuis AS, Vitins AP, Pennings JL et al (2013) Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo cyclosporine A-induced cholestasis. Toxicol Lett 221(3):225–236. doi:10.1016/j.toxlet.2013.06.236
Klawitter J, Gottschalk S, Hainz C, Leibfritz D, Christians U, Serkova NJ (2010) Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism. Chem Res Toxicol 23(3):608–619. doi:10.1021/tx900351q
Kuny S, Gaillard F, Sauve Y (2012) Differential gene expression in eyecup and retina of a mouse model of Stargardt-like macular dystrophy (STGD3). Invest Ophthalmol Vis Sci 53(2):664–675. doi:10.1167/iovs.11-8418
Kuschal C, Thoms KM, Schubert S et al (2012) Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair. Exp Dermatol 21(1):2–6. doi:10.1111/j.1600-0625.2011.01413.x
Lally C, Healy E, Ryan MP (1999) Cyclosporine A-induced cell cycle arrest and cell death in renal epithelial cells. Kidney Int 56(4):1254–1257. doi:10.1046/j.1523-1755.1999.00696.x
Luebke RW, Holsapple MP, Ladics GS et al (2006) Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process. Toxicol Sci 94(1):22–27. doi:10.1093/toxsci/kfl074
Lyons PA, Koukoulaki M, Hatton A et al (2007) Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 8:64. doi:10.1186/1471-2164-8-64
Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401–426. doi:10.1146/annurev-pharmtox-011112-140320
Magkoufopoulou C, Claessen SM, Jennen DG, Kleinjans JC, van Delft JH (2011) Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis 26(5):593–604. doi:10.1093/mutage/ger021
Mascarell L, Truffa-Bachi P (2003) New aspects of cyclosporin a mode of action: from gene silencing to gene up-regulation. Mini Rev Med Chem 3(3):205–214
O’Connell S, Tuite N, Slattery C, Ryan MP, McMorrow T (2012) Cyclosporine A-induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci 126(1):101–113. doi:10.1093/toxsci/kfr330
Ohga K, Takezawa R, Arakida Y, Shimizu Y, Ishikawa J (2008) Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo. Int Immunopharmacol 8(13–14):1787–1792. doi:10.1016/j.intimp.2008.08.016
Ponticelli C (2005) Cyclosporine: from renal transplantation to autoimmune diseases. Ann N Y Acad Sci 1051:551–558. doi:10.1196/annals.1361.099
Sakuma K, Nakao R, Aoi W et al (2005) Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration. Acta Neuropathol 110(3):269–280. doi:10.1007/s00401-005-1049-x
Schaap MM, Zwart EP, Wackers PF et al (2012) Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes. Arch Toxicol 86(11):1717–1727. doi:10.1007/s00204-012-0883-6
Schmeits PC, Volger OL, Zandvliet ET, van Loveren H, Peijnenburg AA, Hendriksen PJ (2013) Assessment of the usefulness of the murine cytotoxic T cell line CTLL-2 for immunotoxicity screening by transcriptomics. Toxicol Lett 217(1):1–13. doi:10.1016/j.toxlet.2012.12.005
Schmeits PC, Katika MR, Peijnenburg AA, van Loveren H, Hendriksen PJ (2014a) DON shares a similar mode of action as the ribotoxic stress inducer anisomycin while TBTO shares ER stress patterns with the ER stress inducer thapsigargin based on comparative gene expression profiling in Jurkat T cells. Toxicol Lett 224(3):395–406. doi:10.1016/j.toxlet.2013.11.005
Schmeits PCJ, van Kol S, van Loveren H, Peijnenburg AACM, Hendriksen PJM (2014b) The effects of tributyltin oxide and deoxynivalenol on the transcriptome of the mouse thymoma cell line EL-4. Toxicol Res. doi:10.1039/C3TX50100K
Shaffer AL, Rosenwald A, Hurt EM et al (2001) Signatures of the immune response. Immunity 15(3):375–385
Shao J, Katika MR, Schmeits PC et al (2013) Toxicogenomics-based identification of mechanisms for direct immunotoxicity. Toxicol Sci 135(2):328–346. doi:10.1093/toxsci/kft151
Shin DH, Park HM, Jung KA et al (2010) The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radic Biol Med 48(8):1051–1063. doi:10.1016/j.freeradbiomed.2010.01.021
Stepkowski SM, Kirken RA (2000) The role of IL-2 in allograft rejection–a lesson learned from experimental work. Transplantation 69(12):2480–2482
Strauss G, Osen W, Debatin KM (2002) Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol 128(2):255–266
Su AI, Wiltshire T, Batalov S et al (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101(16):6062–6067. doi:10.1073/pnas.0400782101
Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545–15550. doi:10.1073/pnas.0506580102
Tariq M, Morais C, Sobki S, Al Sulaiman M, Al Khader A (1999) N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 14(4):923–929
Tomono M, Toyoshima K, Ito M, Amano H (1996) Calcineurin is essential for DNA synthesis in Swiss 3T3 fibroblasts. Biochem J 317(Pt 3):675–680
Tyrrell RM, Basu-Modak S (1994) Transient enhancement of heme oxygenase 1 mRNA accumulation: a marker of oxidative stress to eukaryotic cells. Methods Enzymol 234:224–235
van Kol SW, Hendriksen PJ, van Loveren H, Peijnenburg A (2011) The effects of deoxynivalenol on gene expression in the murine thymus. Toxicol Appl Pharmacol 250(3):299–311. doi:10.1016/j.taap.2010.11.001
van Kreijl CF, McAnulty PA, Beems RB et al (2001) Xpa and Xpa/p53± knockout mice: overview of available data. Toxicol Pathol 29(Suppl):117–127
Whitfield ML, Sherlock G, Saldanha AJ et al (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13(6):1977–2000. doi:10.1091/mbc.02-02-0030
Wilmes A, Limonciel A, Aschauer L et al (2013) Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics 79:180–194. doi:10.1016/j.jprot.2012.11.022
Wolf G, Thaiss F, Stahl RA (1995) Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 60(3):237–241
Yonish-Rouach E, Kimchi A, Rubinstein M (1991) The antiproliferative effect of cyclosporine on hematopoietic and lymphoblastoid cell lines: common mechanistic elements with interferon-alpha. Transplantation 51(6):1276–1282
Ziegler SF, Ramsdell F, Alderson MR (1994) The activation antigen CD69. Stem Cells 12(5):456–465. doi:10.1002/stem.5530120502
Zupanska A, Dziembowska M, Ellert-Miklaszewska A, Gaweda-Walerych K, Kaminska B (2005) Cyclosporine A induces growth arrest or programmed cell death of human glioma cells. Neurochem Int 47(6):430–441. doi:10.1016/j.neuint.2005.05.010
Acknowledgments
This study was financially supported by the Netherlands Genomics Initiative, the Netherlands Organisation for Scientific Research, and the Netherlands Toxicogenomics Centre (Grant Number 05060510).
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Schmeits, P.C.J., Schaap, M.M., Luijten, M. et al. Detection of the mechanism of immunotoxicity of cyclosporine A in murine in vitro and in vivo models. Arch Toxicol 89, 2325–2337 (2015). https://doi.org/10.1007/s00204-014-1365-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-014-1365-9